Cover Image

Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028)

This Phase I study evaluated the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine (PCV), via subcutaneous (SC) or intramuscular (IM) administration, in healthy Japanese infants 3 months of age. A total of 133 participants were randomized to receive four do...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasunori Ishihara (Author), Haruo Kuroki (Author), Hidenobu Hidaka (Author), Kazuyuki Iwai (Author), Keiko Wan (Author), Masayoshi Shirakawa (Author), Miyuki Sawata (Author)
Format: Book
Published: Taylor & Francis Group, 2023-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items